MLEC vs BYND

For growth investors, Moolec Science S.

A. (MLEC) is the stronger pick with 58. 3% revenue growth year-over-year, versus -15. 6% for Beyond Meat, Inc. (BYND). Analysts rate Beyond Meat, Inc. (BYND) a "Sell" — based on 21 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Moolec Science S.

A. (MLEC) delivered a total return of -8. 0%, compared to -99. 2% for Beyond Meat, Inc. (BYND). Over 10 years, the gap is even starker: MLEC returned -8. 5% versus BYND's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Moolec Science S.

A. (MLEC) is the lower-risk stock at 0. 89β versus Beyond Meat, Inc. 's 1. 67β — meaning BYND is approximately 89% more volatile than MLEC relative to the S&P 500.

By revenue growth (latest reported year), Moolec Science S.

A. (MLEC) is pulling ahead at 58. 3% versus -15. 6% for Beyond Meat, Inc. (BYND). On earnings-per-share growth, the picture is similar: Beyond Meat, Inc. grew EPS 24. 7% year-over-year, compared to -89. 8% for Moolec Science S. A.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Beyond Meat, Inc.

(BYND) is the more profitable company, earning 79. 8% net margin versus -33. 4% for Moolec Science S. A. — meaning it keeps 79. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MLEC leads at -3. 1% versus -84. 7% for BYND. At the gross margin level — before operating expenses — MLEC leads at 34. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Moolec Science S.

A. (MLEC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 89)). Beyond Meat, Inc. (BYND) carries a higher beta of 1. 67 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MLEC: -8. 5%, BYND: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (MLEC (Healthcare) and BYND (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MLEC is a small-cap high-growth stock; BYND is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.